Beyond Preeclampsia: Recognizing and Responding to Rare Complications
Addressing the Unmet Needs of Myotonic Dystrophy Type 1 (DM1)
BTK Inhibitor Treatment Options for Smoldering MS
Webinar | 0.75 - 45 mins | Interactive Case | Rheumatology | Biosimilars | BiosimilarsCME.org | Online |
A ACCME Accredited provider.
The France Foundation ©
Chandler Building, 84 Lyme Street, Old Lyme, CT USA